News Scancell expands cancer research deal with Karolinska Instit... Research will develop drugs in a wider range of cancers
Partner Content Partner Content Immuno-Oncology challenges include identifying patients befo... Challenges facing Immuno-Oncology industry
News EU regulators reject new use for Opdivo, as Keytruda edges a... Keytruda begins to win battle of the immunotherapies
News Lung cancer drug Keytruda to become routinely available on N... NICE has given the green light for lung cancer drug Keytruda to be used as a routine treatment for certain patients in England.
News Isomorphic adds MSD to partner roster, and other deals It's been a busy dealmaking week, with Isomorphic Labs, fresh from a $5 billion financing, adding MSD to its list of research alliances.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.